Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours;Impatto della fusione di immagini SPECT/TC con 111In-DTPA- octreotide nel management dei tumori neuroendocrini

Radiologia Medica

Volumn 113, Issue 7, 2008, Pages 1056-1067

  Castaldi, P ^a   Rufini, V ^a   Treglia, G ^a   Bruno, I ^a   Perotti, G ^a   Stifano, G ^a   Barbaro, B ^a   Giordano, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Fusion images; Neuroendocrine tumours; SPECT CT

Indexed keywords

PENTETREOTIDE IN 111; 111IN OCTREOTIDE, DTPA(0); 111IN-OCTREOTIDE, DTPA(0)-; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHUS CARCINOID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FALSE POSITIVE RESULT; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; MALE; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PARAGANGLIOMA; PHYSICIAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID MEDULLARY CARCINOMA; X RAY ANALYSIS; COMPARATIVE STUDY; EVALUATION; INSTRUMENTATION; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55949124418     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-008-0319-9     Document Type: Article

References (29)

1. E. Bombardieri M. Maccauro E. de Deckere 2001 Nuclear Medicine imaging of neuroendocrine tumours Ann Oncol 12 [Suppl2] S51 S61
2. D. Rubello V. Rufini E. De Carlo 2003 New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues Minerva Endocrinol 28 259 296
3. Solcia E, Kloeppel G, Sobin LH (2000) Histological typing of endocrine tumors. In: World Health Organization International Histological Classification of Endocrine Tumors, 2nd edn. Springer, Berlin Heidelberg New York, pp 56-68
4. V. Rufini M.L. Calcagni R.P. Baum 2006 Imaging of neuroendocrine tumors Semin Nucl Med 36 228 247
5. F. Gibril J.C. Reynolds J.L. Doppman 1996 Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas Ann Intern Med 125 26 34
6. R. Lebtahi G. Cadiot L. Sarda 1997 Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors J Nucl Med 38 853 858
7. A. Chiti S. Fanti G. Savelli 1998 Comparison of somatostatin receptor imaging, computer tomography and ultrasound in the clinical management of neuroendocrine gastro-enteropancreatic tumours Eur J Nucl Med 25 1396 1403
8. O. Schillaci R. Danieli C. Manni 2004 Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 25 705 710
9. O. Schillaci 2005 Hybrid SPECT/CT: a new era for SPECT imaging? Eur J Nucl Med Mol Imaging 32 521 524
10. M. Gabriel F. Hausler R. Bale 2005 Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours Eur J Nucl Med Mol Imaging 32 1440 1451
11. J.A. Patton D. Delbeke M.P. Sandler 2000 Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps J Nucl Med 41 1364 1368
12. E. Even-Sapir Z. Keidar J. Sachs 2001 The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms J Nucl Med 42 998 1004
13. G.A. Kaltsas G.M. Besser A.B. Grossman 2004 The diagnosis and medical management of advanced neuroendocrine tumors Endoc Rev 25 458 511
14. S. Li M. Beheshti 2005 The radionuclide molecular imaging and therapy of neuroendocrine tumors Curr Cancer Drug Targets 5 139 148
15. E. Seregni A. Chiti E. Bombardieri 1998 Radionuclide imaging of neuroendocrine tumours biological basis and diagnostic results Eur J Nucl Med 25 639 658
16. D. Hoyer G.I. Bell M. Berelowitz 1995 Classification and nomenclature of somatostatin receptors Trends Pharmacol Sci 16 86 88
17. W. Shi C.F. Johnston K.D. Buchanan 1998 Localization of neuroendocrine tumors with 111In-DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging QJM 91 295 301
18. B. Kumbasar I.R. Kamel A. Tekes 2004 Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS Abdom Imaging 29 696 702
19. C. Perault C. Schvartz H. Wampach 1997 Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne J Nucl Med 38 1234 1242
20. H. Amthauer T. Denecke T. Rohlfing 2005 Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours Eur Radiol 15 1456 1462
21. M. Bocher A. Balan Y. Krausz 2000 Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images Eur J Nucl Med 27 619 627
22. Y. Krausz Z. Keidar I. Kogan 2003 SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours Clin Endocrinol (Oxf) 59 565 573
23. S. Ozer G. Dobrozemsky O. Kienast 2004 Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy Nuklearmedizin 43 164 170
24. K. Tharp O. Israel J. Hausmann 2004 Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma Eur J Nucl Med Mol Imaging 31 1435 1442
25. P.G. Hillel E.J. van Beek C. Taylor 2006 The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours Clin Radiol 61 579 587
26. A.C. Pfannenberg S.M. Eschmann M. Horger 2003 Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms Eur J Nucl Med Mol Imaging 30 835 843
27. J. Ruf I. Steffen S. Mehl 2007 Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT Nucl Med Commun 28 782 788
28. I. Buchmann M. Henze S. Engelbrecht 2007 Comparison of 68Ga-DOATATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours Eur J Nucl Med Mol Imaging 34 1617 1626
29. M. Gabriel C. Decristoforo D. Kendler 2007 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT J Nucl Med 48 508 518